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ABSTRACT 
 
In kidney, filtration of plasma takes place in the glomerular capillary tuft surrounded by urinary 
space and Bowmans´s capsule. The ultrafiltration barrier in the capillary wall comprises three 
layers: fenestrated endothelium, glomerular basement membrane (GBM), and epithelial cell 
(podocyte) layer with distal foot processes and interposed slit diaphragms (SDs). The flow of 
glomerular filtrate follows the extracellular route: passing through endothelial fenestrations, across 
the GBM and then across the SDs, which bridge adjacent foot processes just above the GBM. The 
latest discoveries in the genetic diseases have suggested that podocytes and their SDs are the most 
crucial components of the glomerular filter.  
 
Kidney diseases manifest as renal insufficiency or proteinuria. Heavy proteinuria results in 
nephrotic syndrome. Minimal change nephrotic syndrome (MCNS) is the most common form of 
nephrotic syndrome in childhood and the major problem in pediatric nephrology. The 
pathophysiology of MCNS is not known. Most patients respond to steroid treatment and other 
immunosuppressive drugs suggesting that MCNS has an immunological basis. No visible 
inflammation, however, is present in kidney glomerulus. Also, it is not known which part of the 
glomerular sieve is affected in MCNS. The aim of this work was to study the role of podocytes and 
their SDs in the pathogenesis of MCNS. The role of the major SD component, nephrin, as well as 
the other known SD components, podocin, NEPH1, and CD2AP, were analyzed. Also, the clinical 
features and long-term outcome were evaluated in patients who presented with MCNS in childhood.  
 
The structure of the SD in MCNS kidneys was studied using transmission electron microscopy 
(EM), scanning EM, and immuno-EM. A remarkable reduction was found in the SD number in 
MCNS glomeruli. The proportion of the detectable SDs was reduced by 39% in kidneys from 
MCNS patients as compared to controls. The detection rate was enhanced by changing the viewing 
angle in a tilting series, which revealed the linear image of SDs in 71% and 26% of the slit pores in 
control and MCNS kidneys (p=0.0003). The results suggest that SDs are involved in the 
pathogenesis of MCNS.  
 
The structural changes of podocyte foot processes were evaluated in MCNS kidneys with various 
degree of proteinuria as well as in those with congenital nephrosis of the Finnish type (NPHS1). 
The results showed that the number of podocyte slits was decreased by 60-80 % in proteinuric 
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kidneys due to the effacement of the foot processes, which was observed also in nonproteinuric 
MCNS kidneys. In contrast to the prevailing hypothesis, no detachment of foot processes from the 
GBM could be seen either in MCNS or NPHS1 kidneys. The number of pinocytic invaginations in 
podocytes was also comparable to that seen in control kidneys. Interestingly, nephrin was located in 
the apical part of podocyte foot processes in the narrow MCNS slit pores indicating vertical transfer 
of the SD complex in proteinuria. The results suggest that the protein leakage occurs through the 
defective podocyte slits in both MCNS and in NPHS1 and the other structural alterations seen in 
EM are secondary to the development of proteinuria.  
 
The role of nephrin in the pathophysiology of MCNS was further studied by direct sequencing of 
NPHS1 gene in 38 patients with a biopsy-proven MCNS. The analysis of the NPHS1 coding region 
did not reveal any specific MCNS-associated mutation, but seven of the 38 patients had 
heterozygous amino acid substitutions probably leading to unfavorable conformational changes in 
the nephrin structure. These heterozygous allelic variants lead to five different nonconservative 
amino acid substitutions not previously reported (G879R; R800C; T294I; A916S; S1058L). One of 
the seven patients also had the Fin-major mutation, and two had new, conservative amino acid 
substitutions (S786N; A342G). The results suggest that genetic changes in nephrin may have a 
pathogenetic role in some patients with MCNS.  
 
In order to get more insight into pathogenesis of MCNS and the possible role of genes encoding SD 
proteins, a clinical and genetic evaluation was performed on 104 adults, who had MCNS in 
childhood. Clinical features and outcome were studied, and also three other candidate genes 
encoding for SD proteins (podocin, NEPH1, and CD2AP) were sequenced in 38 subjects with 
MCNS of varying severity. MCNS was detected at the mean age of 5 years (range 8 months to 13 
years) and lasted an average of 5 years. Eighty percent of the patients relapsed 1-28 (median 3) 
times during childhood. Fourteen patients (13.5 %) continued to have proteinuric episodes also as 
an adult. Three of them had occasional proteinuria without clinical manifestations. However, the 
overall health of the participants was good and nobody had renal failure. The prevalence of non-
renal health problems was similar to that in general population and no familial clustering of MCNS 
was observed. Finally, the genetic analyses revealed heterozygous amino acid changes in nephrin 
and podocin genes in seven and five patients, respectively. Three of the nine subjects with 
proteinuria still as an adult had mutations in nephrin and podocin genes. In contrast, NEPH1 and 
CD2AP genes were highly conserved and no significant changes were detected.  
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In conclusion, the results of this study suggest that a defective podocyte filtration slit is the probable 
route for protein leakage in acquired nephrotic diseases such as MCNS. The genetic variants of 
glomerular filter proteins may predispose to proteinuria in some MCNS patients. However, MCNS 
is a multifactorial disease with little familial clustering. A fuller understanding of the molecular 
mechanisms behind proteinuria and disruption of the slit diaphragm complex needs further 
clarification. In this respect, the relationship between the podocytes and the immunological system 
seems important.  
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 REVIEW OF THE LITERATURE 
1. NORMAL GLOMERULAR FILTRATION 
1.1 Physiology 
 
The major function of the kidney is to regulate the composition of the extracellular fluid. This is 
enabled by selectively adjusting the composition of the plasma that flows through the renal 
vasculature so that materials to be conserved are retained in plasma and waste products from 
metabolism are excreted in the urine (Renkin and Robinson, 1974). The formation of the urine 
involves three processes: filtration, reabsorption, and secretion. These are known to take place in 
the million nephrons of a kidney (Nyengaard and Bendtsen, 1992) (Figure 1).  
 
 
Figure 1. Nephron is the functional unit of the kidney glomerulus. 
 
Nephron is the functional unit of the kidney consisting of a twisted capillary tuft (glomerulus), a 
Bowman´s capsule, and a tubular system. The primary function of the glomerulus is to form a 
filtrate of the blood plasma. Filtration is driven by the effective hydrostatic pressure of the plasma 
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within the glomerular capillaries (Figure 2). In this process plasma water and small molecules are 
separated from blood cells and protein macromolecules, which remain in the circulation. Renal 
blood flow comprises approximately 20-30% of the cardiac output. Subsequently, every day nearly 
180 litres of a primary filtrate crosses the glomerular capillary walls and enters the urinary space 
within the Bowman´s capsule (Renkin and Robinson, 1974). This acellular and almost protein free 
filtrate exits the capsule in the urinary pole, leading first into the proximal convoluted tubule of the 
nephron (Figure 2). Due to the enormous reabsorption capacity of the tubular system, the volume of 
the filtrate is reduced by about 99% before elimination from the body. As a result, the final urine 
volume of a normal adult totals 1 to 1.5 litres per day.  
 
 
 
 
Figure 2. Filtration occurs in kidney glomeruli by passing of the small plasma molecules and water 
from the capillary lumen into the surrounding urinary space. 
 
 
Glomerular sieving is based on the size, shape, and charge of the macromolecule (Pavenstadt et al., 
2003). While a high permeability is allowed to water and small molecules, there is an efficient 
selectivity that restricts cells, proteins larger than albumin (69kDa), and anionic molecules to cross 
the capillary wall. Passage of negatively charged molecules is prevented by the negative charge of 
many components of the capillary wall including capillary endothelium, basement membrane and 
an outer layer of epithelial cells. The net anionic charge results from the presence of negatively 
charged glycoproteins and heparin sulfate proteoglycans.  
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1.2 Anatomy 
 
The glomerular capillary walls constitute the plasma filtration barrier (Figure 3). The filtration 
barrier is composed of three layers: a fenestrated endothelium, the glomerular basement membrane 
(GBM), and an epithelial cell (podocyte) layer with distal foot processes. A key component of the 
glomerular epithelium is a specific cell-cell junction of the neighboring podocyte foot processes 
known as a slit diaphragm (SD). When crossing the capillary wall, glomerular filtrate follows an 
extracellular path: through fenestrae, across the GBM, and finally through the slit diaphragms. 
 
 
 
 
Figure 3. Capillary wall forms the primary filter consisting of three layers: endothelium, glomerular 
basement membrane and epithelial cell layer.  
 
1.2.1 Endothelium 
 
Specialized endothelial cells line the internal surface of the capillary being exposed to all circulating 
blood components. These cells have a special position at the interface between blood and tissue and 
an active role in controlling coagulation, inflammation and immune processes within the 
glomerulus (Savage, 1994). The glomerular endothelium is perforated by numerous fenestrations, 
which unlike most fenestrations of endothelial cells lack diaphragm. To some extent, open 
fenestrations 70-100 nm in diameter can serve as a size selective barrier to blood cells and to large 
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macromolecules. In addition, there is a negative charge of the endothelial plasma membrane, which 
may also have some barrier properties. However, the layer of endothelial cells is very permeable 
and the main barrier is established by the underlying basement basement membrane and glomerular 
podocytes.  
1.2.2 Glomerular basement membrane (GBM) 
 
A 300-nm thick glomerular basement membrane (GBM) is the product of both endothelial cells and 
podocytes. Basement membrane is a network of proteins including collagens, laminins, nidogen, 
and heparan sulfate proteoglycans (Leblond and Inoue, 1989; Aumailley, 1995). The major 
collagenous component of the basement membrane is collagen IV. In mature glomeruli, collagen IV 
is predominantly composed of α3, α4, and α5 chain isoforms. The most abundant non-collagenous 
component of the GBM is laminin. Laminin is a glycoprotein that is thought to be important 
molecule in linking together the GBM constituents (Smith et al., 1989; Virtanen et al., 1995). 
Laminin plays also a role in anchoring the podocyte foot processes to the GBM. In addition to 
laminin, also collagen IV and nidogen bind to α3β1-integrin, which connects them to the 
cytoskeletal components of the foot processes (Kreidberg, 2000; Barisoni and Mundel, 2003). 
Heparane sulfate proteoglycans such as agrin and perlecan constitute the overall negative charge of 
the GBM (Raats et al., 2000). The GBM gives mechanical support to the glomerular filter and takes 
part in protein sieving. For decades, alterations in the GBM were thought to be responsible for the 
protein leakage.  
 
1.2.3 Visceral epithelium (podocytes) 
 
The outermost layer of the capillary wall forms the final and most critical filtration barrier 
(Pavenstadt et al., 2003; Jalanko et al., 2001). This layer is composed of visceral epithelial cells 
known as podocytes. The name comes from their long and extensive foot processes. Podocyte is 
divided into four segments: cell body, (primary) major processes, secondary processes, and terminal 
pedicles known as foot processes. The adjacent foot processes cover the GBM leaving 30-40-nm 
wide interpodocyte spaces (slit pores, filtration slits) in between (Figure 3). Each slit pore is bridged 
by a thin slit diaphragm (SD), which connects the foot processes of neighboring cells (Yamada, 
1955). The maintenance of the SD seems to be the most precipitous factor in preventing vascular 
leak. 
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 Podocyte surface is divided into two segments by the SD: the luminal side upon the level of the SD, 
and the side beneath the SD, which faces the GBM. The apical surface facing the urinary space is 
covered by a glycocalyx. The glycocalyx contains sialylated glycoconjugates and sulfated 
molecules and forms a highly negative charged cell surface coat, called epithelial polyanion, 
contributing to the negative charge of the filtration barrier. The major sialoglycoprotein constituting 
this negative charge is podocalyxin (Kerjaschki et al., 1984), which is involved in formation and 
stabilizing the cellular architecture of podocytes and the filtration slits (Kerjaschki et al., 1984; 
Takeda et al., 2001). 
 
Podocyte cytoskeleton contains a contractile system, which is composed of actin, myosin-II, α-
actinin-4, talin and vinculin (Figure 4) (Drenckhahn and Franke, 1988). The major molecular 
constituents of the foot process cytoskeleton are actin, α-actinin, and synaptopodin (Mundel et al., 
1997). Experimental studies using model systems of nephrotic syndrome have shown that 
reorganization of the actin cytoskeleton is preceded by upregulation of α-actinin, which serves as an 
actin cross-linking protein (Smoyer et al., 1997). The clinical relevance of these molecules, which 
serve to maintain the cytoskeletal architecture, was elucidated when mutations in the ACTN gene 
coding for α-actinin-4, were shown to cause familial focal segmental glomerulosclerosis (FSGS) 
(Kaplan et al., 2000). 
 
Figure 4. The SD area has been reported to contain at least nephrin, NEPH1, FAT1, and P-cadherin 
interacting with each other and also with the cytosolic adapter proteins podocin, CD2AP, and ZO-1. 
The adapter proteins connect the SD with the actin cytoskeleton of the foot processes. 
 
Maintenance of the podocyte architecture involves also that the foot processes adhere to the GBM. 
This is controlled by the expression of integrins and dystroglycans, which are connected to the 
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podocyte actin cytoskeleton and also bind to several components of the GBM (Figure 4) (Adler, 
1992; Raats et al., 2000).  
 
Podocytes seem to be crucially involved in establishing the specific permeability properties of the 
filter, but their specific function is still unknown. It has been speculated that the filament system 
composed of actin, myosin, and α-actinin, allows the foot processes to generate a contractile force, 
which would then enable the foot processes to resist the high intraluminal hydrostatic pressure of 
the capillaries and to actively modify the filtration surface (Drenckhahn and Franke, 1988). Also, it 
has been suggested that the podocyte may function as the cell responsible for the continuous 
cleaning of the filter (Pavenstadt et al., 2003).  
 
1.2.4 Slit diaphragm (SD) 
 
Slit diaphragm is seen as a filamentous structure bridging the gap between interdigitating foot 
processes in transmission electron microscopy (TEM)(Yamada, 1955)(Figure 5). The gap where 
neighboring podocytes contact with each other, is also known as a slit pore or a filtration slit. Slit 
pores are shown to have a constant width of 30- to 40 nm (Rodewald and Karnovsky, 1974; 
Furukawa et al., 1991). SD is actually an extracellular meshwork of proteins anchored at the sides 
of the foot processes which is suggested to be a modified adherens junction (Figure 5) (Farquhar et 
al., 1999; Benzing, 2004; Wartiovaara et al., 2004). This specialized structure of cell-cell contact 
seems to represent the main size selective filter barrier in the kidney.  
 
 
Figure 5. In transmission electron microscopy, SD is seen as a filamentous structure connecting the 
adjacent foot processes. Nephrin and NEPH1 associate with each other extracellularly and form the 
backbone of SD. The molecular organization of SD is so far hypothetical. Also dendrin, NEPH2, 
FAT1, FAT2, and P-cadherin are located at the SD.  
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The first protein demonstrated to be present in slit diaphragm was ZO-1 (Schnabel et al., 1990). 
This tight junction protein has been identified on the cytoplasmic face of the SD and is known to 
interact with the actin cytoskeleton of the podocyte, but the functional relevance of ZO-1 is still 
unknown (Yuan et al., 2002).  
 
The major component of the SD was identified when a novel transmembrane protein nephrin 
(NPHS1) was specifically located at the SD area (Ruotsalainen et al., 1999; Holthofer et al., 1999). 
The gene coding for nephrin (NPHS1) had been discovered a year earlier and was shown to be 
mutated in the congenital nephrosis of the Finnish type (CNF) (Kestila et al., 1998). Nephrin is a 
185-kDa transmembrane protein, which contains eight extracellular immunoglobulin (Ig) domains, 
one fibronectin motif and a short cytoplasmic tail. The intracellular domain has nine tyrosine 
residues, some of which become phosphorylated during ligand binding. 
 
Since the discovery of nephrin, a lot of effort has been put in piecing together the molecular 
composition of the SD and there has been a fast growing number of other slit diaphragm proteins 
(Figure 5). There are now at least eight molecules identified in the SD area: nephrin, podocin, 
CD2AP, ZO-1, NEPH-1, FAT1, P-cadherin, dendrin, and filtrin (Ihalmo et al., 2003). Nephrin, 
Neph1, podocin, and CD2AP are shown to interact with each other and to be embedded into 
structures called lipid rafts (Schwarz et al., 2001). The lipid raft is a specialized part of a membrane, 
which is enriched in cholesterol, glycosphingolipids and GPI anchored proteins. This membrane 
domain has a functional role in biologic processes such as cell adhesion, exocytosis, endocytosis, 
and signal transduction (Simons and Ikonen, 1997).  
 
Experimental studies have demonstrated that nephrin and podocin form a functional complex, and 
association of podocin with lipid raft microdomains of the plasma membrane is needed for 
recruitment of nephrin into rafts (Huber et al., 2003). Further studies on nephrin interacting 
molecules have recently verified that nephrin forms a multiprotein complex with cadherins and 
p120 catenin and with three scaffolding proteins, ZO-1, CD2AP, and CASK. CASK is a novel 
binding partner of nephrin, which participates in maintenance of polarized epithelial cell 
architecture by linking membrane proteins and signaling molecules to the actin cytoskeleton 
(Lehtonen et al., 2004). 
 
Podocin (NPHS2) localizes to the membrane of foot processes at the insertion site of the SD 
(Roselli et al., 2002). Podocin is an integral membrane protein, which forms a hairpin like structure 
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having its two ends in the cytoplasm of the foot processes. Mutations in the NPHS2 gene cause both 
familial (Boute et al., 2000; Koziell et al., 2002) and sporadic steroid-resistant nephrotic syndrome 
(SRNS) (Karle et al., 2002; Frishberg et al., 2002; Tsukaguchi et al., 2002; Caridi et al., 2003). 
Recently Huber et al demonstrated that mutations in the NPHS2 gene disrupt nephrin targeting to 
lipid raft microdomains (Huber et al., 2003). This has been suggested to be possible 
pathomechanism of SRNS. 
 
CD2-associated protein (CD2AP) is an 80-kDa protein which was originally found to interact with 
CD2-receptor in T lymphocytes (Dustin et al., 1998). Later on, it turned out that CD2AP is also an 
adapter molecule in podocytes interacting with nephrin. It was demonstrated that CD2AP deficient 
mice died several weeks after birth with foot processes effacement and nephrotic syndrome (Shih et 
al., 1999). In addition, a heterozygous mutation in the CD2AP gene has been reported in two human 
patients with FSGS (Kim et al., 2003). CD2AP is shown to interact directly with actin cytoskeleton. 
Disruption of this actin cytoskeleton results in disorganization of endogenous CD2AP (Lehtonen et 
al., 2002). Recent studies have also indicated that CD2AP functions as a selective mediator of anti-
apoptotic TGF-beta signaling (Schiffer et al., 2004) .  
 
When Donoviel et al. searched for nephrin homologues from databases, they identified a mouse 
gene, Neph1 (Donoviel et al., 2001). Neph1 protein has five extracellular Ig-domains and a single 
transmembrane domain. Thus Neph1 is structurally related to nephrin and is also a member of the 
immunoglobulin superfamily. Mice lacking Neph1 are demonstrated to develop a nephrotic 
syndrome, but so far there is no evidence of a NEPH1-related disease phenotype in humans. In 
addition, Neph1 is shown to interact with the C-terminal domain of podocin (Sellin et al., 2003). 
This nephrin homologue seems to be an additional SD component, which has an important role in 
maintaining the integrity of the slit diaphragm.  
 
P-cadherin has been detected in mouse kidneys to co-localize with ZO-1 at the level of the SD, but 
mice deficient of P-cadherin neither generate proteinuria nor present a certain renal phenotype 
(Radice et al., 1997). FAT1, a member of cadherin superfamily, has also been identified in the SD 
area but its function in mammalian tissues remains to be established (Inoue et al., 2001). Most 
recently two additional proteins, dendrin and filtrin have also been located in SD (Mundel et al., 
2004; Ihalmo et al., 2003).  
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Nephrin and the other SD proteins are known to take part in cell signaling. The tyrosine residues of 
the intracellular part of nephrin are phosphorylated by Src family kinases Fyn and Src (Li et al., 
2004). Li et al. found that Fyn phosphorylated effectively the cytoplasmic domain of nephrin, which 
enhanced the interaction of nephrin and podocin. Huber et al demonstrated that both nephrin and 
CD2AP interact with the p85 regulatory subunit of PI3K in vivo, which stimulated PI3K-dependent 
AKT signaling in podocytes (Huber et al., 2003). Nephrin-induced AKT phosphorylates several 
target proteins in podocytes. One of them is Bad, which has a role in protecting podocytes from 
detachment-induced cell death. Thus, in addition to their structural functions, nephrin, CD2AP, and 
podocin are involved in regulation of complex biological programs such as apoptosis (Huber et al., 
2003).  
 
Most recently, Coward et al studied the SD-dependent signaling in cultured human podocytes 
(Coward et al., 2005). One of their findings was that intracellular calcium signaling mediated by 
tyrosine kinase phosphorylation, was altered when cultured podocytes were exposured to nephrotic 
plasma of human origin. The exposure lead to cytoplasmic redistribution of nephrin, podocin and 
CD2AP in podocytes, and relocation of nephrin could be rescued by co-incubation with non-
nephrotic plasma. The signaling and translocation response to normal plasma was shown to be 
nephrin dependent (Coward et al., 2005).  
1.2.5 Foot process cytoskeleton 
 
A dynamic actin-based cytoskeleton maintains the normal architecture of the foot processes (Figure 
4). Changes in the foot process organization can result from a primary defect in a cytoskeletal 
component and/or disruption of the interaction of the cytoskeletal component with a SD protein. In 
experimental studies nephrin and podocin are shown to partially co-localize with actin, and 
disruption of nephrin/podocin complex has been suggested to be the final pathway to foot process 
effacement (Saleem et al., 2002).  
 
One of the major components of the podocyte cytoskeleton is α-actinin. Alpha-actinin-4 is an actin 
filament cross-linker shown to be involved in certain form of FSGS (Kaplan et al., 2000; Kaplan 
and Pollak, 2001). Some patients with FSGS are shown to have an autosomal dominant disease, 
which is caused by mutations in the gene encoding α -actinin-4 (ACTN4). In vitro, mutant α -
actinin-4 binds filamentous actin more strongly than wild-type α -actinin-4. In kidneys, podocyte 
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foot processes show partial effacement. Thus, regulation of the actin cytoskeleton of podocytes may 
be altered in this group of patients.  
 
Synaptopodin is another actin-associated protein present in podocyte foot processes. Greater 
expression of this prolin-rich protein has been associated with a better response to corticosteroid 
treatment in patients with MCNS, but it’s role in maintaining the podocyte cytoskeleton is obscure 
(Mundel et al., 1997).  
 
Podocalyxin, the major sialoprotein of glomerular epithelial cells, is known to participate in 
maintaining the architecture of the foot processes. Podocalyxin is linked to ezrin and the actin 
cytoskeleton via a scaffold protein NHERF2 (Na+/H+-exchanger regulatory factor 2). Disruption of 
their interaction leads to loss of foot processes and filtration slits comparable to seen that in 
nephrosis (Takeda et al., 2001; Schmieder et al., 2004). Podocalyxin-deficient mice exhibit 
profound defects in kidney development and die within 24 hours of birth with anuric renal failure. 
Although podocytes are present in the glomeruli of these mice, the formation of foot processes and 
slit diaphragms is failed (Doyonnas et al., 2001). 
 
2. PROTEINURIA 
 
Proteinuria is known to be an independent risk factor for the development of end-stage renal 
disease. Besides predicting renal failure, proteinuria is a predictor of all-cause mortality rates. 
Indeed, glomerular diseases account for the majority of kidney transplantations. It has long been 
known that alterations in the glomerular filtration unit causes the leakage of plasma proteins into the 
urine. Proteinuria results from the loss of integrity of the glomerular capillary wall, but which part 
of it is the most crucial one, has been a matter of debate for long.  
Generally the highly fenestrated endothelial cells of the glomerulus have not been considered to 
have prominent restrictive properties, but also controversial results have been published (Rostgaard 
and Qvortrup, 1997; Bjornson et al., 2005). However, endothelial cells are covered with a cell-
surface coat containing proteoglycans contributing to the glomerular charge barrier (Haldenby et al., 
1994). 
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2.1 GBM and proteinuria  
 
Traditionally, GBM has been considered as the most important component of the filtration 
apparatus (Caulfield and Farquhar, 1974). For decades, proteinuria was thought to be a consequence 
of the decreased anionic charge of the GBM. This negative charge results from the anionic 
polysaccharide side chains of heparan sulfate (HS) proteoglycans present in the GBM. The 
reduction of HS-associated anionic sites in the GBM has been demonstrated in several human 
(Wada et al., 1990; Washizawa et al., 1993; Vernier et al., 1983) and experimental glomerulopathies 
(Sasaki et al., 1989; Batsford et al., 1983; Duan et al., 1993). Moreover, many studies reported an 
inverse correlation between albuminuria and the GBM HS staining (Van den Born et al 1993; Van 
Bruggen et al 1995; Tamsma JT et al 1994; Raats CJI et al 1997).  
 
Complementary observations were made in studies of minimal change nephrotic syndrome (MCNS) 
(Bridges et al., 1982; Carrie et al., 1981; Ramjee et al., 1997). The degree of albuminuria observed 
in MCNS was attributable to a 50% reduction in the concentration of fixed negative charges in the 
glomerular capillary wall (Bridges et al., 1982). Later on Van den Born et al. demonstrated with 
antibodies directed against the agrin core protein and the HS side chain, that HS staining in GBM, 
not staining of the agrin core protein, was decreased in different human proteinuric 
glomerulopathies such as systemic lupus erythematosus (SLE), MCNS, membranous 
glomerulonephritis, and diabetic nephropathy (Tamsma et al., 1994; van den Born et al., 1993). The 
changes in the HS polysaccharide side chain were explained to be generated by four different 
mechanisms: 1. masking by immuno complexes (SLE), 2. depolymerization by radicals, 3. 
degradation by proteolytic enzymes such as elastase, cathepsin G, and heparanase, and 4. 
metabolically-induced biochemical changes in the HS structure which results in an abnormal HS 
content and/or alterations in the sulfation of HS (Raats et al., 2000).  
 
Also, alterations in HS proteoglycans consisting of either decreased number and/or less anionic 
charge were demonstrated to associate with puromycin aminonucleoside (PAN) nephrosis in rats 
(Mahan et al., 1986). Thus, the animal model also suggested that the GBM is needed to maintain the 
structure of epithelial cells. PAN nephrosis in rats has also been used as the model of idiopathic 
nephrotic syndrome in man (Vernier et al., 1959). It has bee suggested that immune cells express 
heparanase, which is able to degrade HS glycosaminoglycan in the glomerular capillary wall and 
induce proteinuria in steroid sensitive NS (Holt et al., 2005).  
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In contrast to data presented above, mice lacking perlecan or agrin, the major proteoglycans of the 
GBM, were demonstrated to have no proteinuria (Zhou et al., 2004; Harvey and Miner, 2005). The 
study on renal phenotype of agrin-deficient mice by Harvey et al. indicated that agrin is not required 
for the establishment of normal glomerular architecture, but it does impart fixed anionic sites to the 
GBM (Harvey and Miner, 2005). These mice died very shortly after birth, but albumin 
concentration in amniotic fluid was similar in mutant and control animals.  
 
Also other components of the GBM are believed to take part in protein sieving. An interesting 
disease in this respect is Alport syndrome, which is caused by mutations in α-chain of type IV 
collagen. X-linked form of Alport syndrome arises from mutations in the gene coding for the α5 
chain (COLA4A5) and mutations in α3 chain (COLA4A3) result in autosomal recessive form. 
Despite of major defects in the GBM structure, these patients manifest with hematuria, modest 
proteinuria and renal failure. Nephrotic range proteinuria is detected in some patients in the terminal 
phase (Jalanko et al., 2003). In accordance with the human data, Hamano et al recently showed that 
mice deficient in α3-chain developed chronic renal failure associated with modest proteinuria 
(Hamano et al., 2002). They demonstrated that significant ultrastructural defects in the GBM along 
with molecular alteration in type IV collagen did not lead to a precipitous glomerular leak.  
 
Interestingly, mice deficient in non-collagenous component of the GBM, laminin, have been shown 
to develop proteinuria (Noakes et al., 1995). Laminin β2 is known to be abundantly expressed in the 
GBM and is thought to play a key role in anchoring of podocyte foot processes. Recently, an 
autosomal recessive entity in man involving congenital nephrosis and eye malformations (Pierson 
syndrome) was linked to laminin β2 deficiency (Zenker et al., 2004). Patients with Pierson 
syndrome from five unrelated families were found to have homozygous or compound heterozygous 
mutations in their LAMB2 gene.  
 
2.2 Podocytes and proteinuria 
 
All forms of nephrotic syndrome (NS) are characterized by abnormalities in the podocyte and injury 
of this cell type typically leads to marked proteinuria (Mundel and Shankland, 2002). In addition, 
genetic studies in patients with familial NS have identified mutations in the genes that encode 
important podocyte proteins.  
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2.2.1 Foot process effacement and the filtration pores 
 
An electron microscope study performed in 1956 by Marilyn Farquhar and her co-workers already 
showed that there is a uniform lesion in nephrosis - loss of foot process organization. They 
concluded: ”it seems most likely that the epithelium may represent the site of original renal damage 
in nephrosis” (Farquhar et al., 1957). The distortion of the epithelial cell structure or loss of foot 
process organization was called foot process effacement (Autio-Harmainen et al., 1981). Whether 
the effacement results from podocyte fusion or retraction and less complex realignment of the foot 
processes, is still unknown.  
 
Glomerular permeability studies in rats with PAN nephrosis showed that both the number and width 
of the filtration slits were considerably decreased in proteinuria (Farquhar et al., 1957; Farquhar and 
Palade, 1961; Caulfield et al., 1976; Ryan et al., 1975). The residual sites of previous slit pores were 
replaced by close appositions of the cell membranes, which appeared tighter and increased in depth. 
In these ”tight” or ”closed” junctions the intercellular space was reduced from 300-450 Å to as little 
as 80 Å (Farquhar and Palade, 1961). Caulfied et al. reported five types of slit pores: (1) normal 
slits, (2) those which are wider than normal, and those which are replaced with either (3) occluding 
junctions, (4) gap junctions, or (5) ladder-like structures (Caulfield et al., 1976). Normal appearing 
slits decreased in frequency as the disease progressed. The widened slits were more frequent in later 
stages of the disease and often lack the SD filament.  
 
The most common change in PAN nephrosis, however, was the conversion of podocyte pores into 
occluding junctions. This was coupled to displacement of the slit diaphragms (Caulfield et al., 
1976). Ryan et al found that, as epithelial spreading occurred, progressively more of the 
interpodocyte slits appeared ”closed” which resulted in the slit diaphragm being displaced away 
from the GBM (Ryan et al., 1975). Furthermore, freeze-fracture studies revealed an extreme 
narrowing of the interepithelial spaces. These junctions, observed in PAN nephrosis, contain 
incomplete fibrils or grooves typical of ”leaky” zonulae occludentes (Ryan et al., 1975). These 
observations in animal models remained without an explanation for over twenty years.  
 
 23
2.2.4 Foot process detachment 
 
Detachment of podocytes from the underlying GBM has been reported to coincidence with 
proteinuria in animal models (Ryan and Karnovsky, 1975; Kanwar and Rosenzweig, 1982; 
Whiteside et al., 1989). Ryan and Karnowsky first proposed that scattered focal defects in the 
external covering of the GBM lead to increased proteinuria in PAN nephrosis (Ryan and 
Karnovsky, 1975). They observed that the loss of foot processes occurred before the onset of 
proteinuria, but the presence of focal defects in the epithelial covering of the GBM developed 
concomitantly with massive proteinuria. A third of the glomeruli in nephrotic rats were reported to 
show areas of externally bare GBM (Ryan and Karnovsky, 1975).  
 
Later on Messina et al, using scanning and transmission EM, demonstrated in the PAN model that 
the sudden onset of nephrotic proteinuria correlated with the small number of ruptures through the 
highly vacuolated glomerular epithelium (Messina et al., 1987). They also found large balloonlike 
spaces overlying the focal segments of bare GBM showing perforation to the urinary space. The 
mechanism of the formation of these epithelial”balloons” remained unclear (Messina et al., 1987). 
Whiteside et al. demonstrated that focal detachment of the epithelium, not the SD loss or podocytic 
effacement, was associated with the sudden increase of proteinuria in both adriamycin and PAN 
nephrosis. Five to 10 areas of denudation per 50 sections of whole glomeruli were observed 
(Whiteside et al., 1989). The striking appearance of holes through the glomerular epithelium on 
scanning EM also appeared in both models.  
 
Kanwar and coworkers (Kanwar and Rosenzweig, 1982) induced the podocyte detachment by 
perfusing kidneys with neuraminidase or by PAN administration. In both models a marked increase 
in the permeability of the glomerular capillary wall to a marker molecule (ferritin) occurred in 
areas, where the epithelium was detached from the underlying GBM, but remained normal where 
the epithelium was adherent. Inokuchi et al. (Inokuchi et al., 1996) found that foot process 
effacement in PAN nephrosis lead to the development of palm-like domains, which correlated with 
podocyte detachment and proteinuria. The basal surface areas increased suddenly when massive 
proteinuria began. On the other hand, the decrease in filtration slit length was gradual and not in 
parallel with proteinuria.  
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In addition to the animal models, focal areas of externally denuded GBM have been observed in the 
glomeruli of nephrotic patients with focal glomerulosclerosis (Grishman and Churg, 1975), and 
amyloidosis (Katafuchi et al., 1984). Yoshikawa et al. found small foci of epithelial detachment in 
16 out of the 33 patients with MCNS and urinary protein excretion above 40 mg/h/m2 (Yoshikawa 
et al., 1982). Urinary podocytes have been detected in FSGS and this has been suggested to be 
useful diagnostic indicator for differentiation between FSGS and MCNS (Nakamura et al., 2000).  
 
Adhesion of the podocyte to the GBM is controlled by the expression of integrins and 
dystroglycans, proteins coupled to the podocyte actin cytoskeleton (Kreidberg, 2000)(Figure 4). 
Reduced expression of dystroglycans is reported to associate with MCNS and coincidence with 
proteinuria suggesting the detachment of the podocytes (Regele 2000). In FSGS, the expression of 
dystroglycans was reported to show no changes. However, focal areas of externally denuded GBM 
have been observed both in the glomeruli from nephrotic patients with FSGS (Grishman and Churg, 
1975) and MCNS (Yoshikawa et al., 1982). 
 
In addition, a decrease in podocyte number has been shown to associate with the development of 
glomerulosclerosis and detachment is suggested to be one of the mechanisms underlying the 
podocyte loss (Mundel and Shankland, 2002). Podocytopenia is thought to involve podocyte injury, 
which then causes the podocytes either to undergo apoptosis or detachment. In addition, appropriate 
proliferation after the injury is needed in restoration of normal podocyte number (Kriz, 1996; Kriz 
and Lehir, 2005). Lately, the phenotype of dystroglycan deficient mice was characterized and 
contrary to all expectations, these mice showed no proteinuria (Harvey and Miner; ASN 2004).  
 
2.2.5 Disruption of the SD 
 
Identification of the mutated genes for the SD proteins has shed new light on our understanding the 
development of proteinuria. It has become evident that the SD is needed to prevent protein leakage.  
In NPHS1 kidneys lacking nephrin, no SDs were seen in the podocyte filtration slits (Patrakka et 
al., 2000) indicating that the absence of nephrin leads to distortion of the SD and the leakage of 
plasma proteins into urine through the”empty” podocyte pores (Wartiovaara et al., 2004). Nephrin-
deficient mice have no SD, but they show normal architecture of the GBM and normal expression 
of various GBM and other SD proteins (Hamano et al., 2002).  
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Experimental studies have also shown that severe proteinuria is associated with disruption of the SD 
(Yuan et al., 2002; Saran et al., 2003; Saleem et al., 2002; Liu et al., 2003): the SDs are either 
absent, displaced or replaced by occluding junctions. It seems that nephrin is a pivotal protein for 
the maintenance of the normal SD structure. Blanco et al. demonstrated recently in rat a model of 
obesity and type II diabetes mellitus that treatment with an angiotensin-converting enzyme (ACE) 
inhibitor corrected podocyte phenotypic changes by affecting their nephrin expression (Blanco et 
al., 2005). Another ultrastructural study showed that nephrin expression and its distribution were 
altered in PAN-treated rats, and this occurred in parallel with foot process effacement (Lee et al., 
2004). The paper by Guan et al. describing key molecular events in PAN-nephrotic rats suggested 
that the first response before the onset of proteinuria was the nephrin and podocin redistribution 
(Guan et al., 2004). Altered distribution of nephrin has been considered as a potential general 
mechanism for proteinuria also in humans (Wernerson et al., 2003; Doublier et al., 2001).  
 
Studies on differentiated podocytes treated with PAN addressed the close relationship between 
nephrin, podocin, and filamentous actin (Saleem et al., 2002). Coimmunoprecipitation experiments 
revealed that nephrin interacts also with Neph1 at the level of the extracellular segment of the SD. 
Dysfunction of the slit diaphragm was shown to be induced by both anti-Neph1 and anti-nephrin 
antibodies (Liu et al., 2003). Also, it seems that primary or secondary changes in the foot process 
cytoskeleton can affect the proper positioning of the transmembrane proteins and lead to the 
disruption of the SD (Saleem et al., 2002).  
 
3. NEPHROTIC KIDNEY DISEASES IN CHILDREN 
 
NS is characterized by heavy proteinuria (>40mg/h/m2), hypoalbuminemia (<25 g/l), 
hyperlipidemia and edema (Eddy and Symons, 2003). Edema is the predominant feature resulting 
from an imbalance between the hydrostatic and colloidal osmotic pressure in the intravascular and 
extracellular compartments. As serum albumin falls below 20g/l, compensatory mechanisms, such 
as activation of the renin-angiotensin-aldosterone axis with an increased tubular reabsorption of 
sodium, further increase the formation of edema. The most important nephrotic kidney diseases in 
Finnish children are MCNS, FSGS, and NPHS1.  
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3.1 Congenital nephrotic syndrome of the Finnish type (NPHS1, CNF) 
 
NPHS1 is a recessively inherited autosomal disorder which is highly enriched in the Finnish 
population, with a frequency of 1/8200 newborns (Hallman et al., 1956; Norio, 1966). NPHS1 
specifically affects the kidney and is characterized by proteinuria already in utero and a severe NS 
soon after birth (Patrakka et al., 2002). The infant is often born prematurely with a low birth weight 
(Huttunen, 1976). However, the NPHS1 child is usually not small for gestational age. For an 
unknown reason, the placenta is disproportionately large weighing more than 25% of the 
birthweight in practically all newborns with NPHS1 (Patrakka et al., 2000). Infants with NPHS1 are 
first treated with daily albumin infusions. When the patient weighs 7 kg, bilateral nephrectomy is 
performed and dialysis commenced. Kidney transplantation, which is the only curative treatment for 
NPHS1, is performed at the age of 1-2 years (Savage et al., 1999; Holmberg et al., 2004).  
 
NPHS1 is caused by mutations in the NPHS1 gene, which encodes the major SD component, 
nephrin. Nephrin is a transmembrane protein of 1241 amino acids with an estimated molecular size 
of 130 kDa. It contains eight extracellular immunoglobulin (Ig) domains, one type III fibronectin 
motif, a transmembrane domain, and an intracellular domain, which contain nine tyrosine residues 
(Figure 6). Based on the predicted domain structure, nephrin is classified as a member of the 
immunoglobulin superfamily of cell adhesion molecules.  
 
 
Figure 6. Nephrin is a 1241 residue transmembrane adhesion protein of the immunoglobulin 
superfamily. The extracellular part of nephrin contains eight immunoglobulin-like motifs and one 
type III fibronectin domain.  
 
NPHS1 has a size of 26 kb and is located on chromosome 19q13.1. It contains 29 exons (Kestilä et 
al., 1998). The two most common mutations, that account for 97% of the CNF cases in Finland, are 
called Fin-major and Fin-minor (Kestilä et al., 1998). Sixty percent of the Finnish patients are 
homozygous for the Fin-major mutation, which is a two base pair deletion (121-122 del CT) in exon 
2 resulting in a frameshift and an early stop codon. The gene product is a truncated protein 
consisting of only 90 amino acids. The Fin-minor mutation is a nonsense mutation (3325 C→T) in 
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exon 26 where a substitution of one nucleotide leads to a stop codon and consequently to a 
truncated protein of 1109 amino acids. Neither of the two products can be detected on the podocyte 
surface by immunohistochemistry or immuno-EM (Patrakka et al., 2000), and no SD is seen in 
transmission electron microscopy of CNF kidneys.  
 
A total of 68 mutations, including deletions, insertions, splicing mutations, nonsense, and missense 
mutations, have been reported in the nephrin gene (Lenkkeri et al., 1999; Koziell et al., 2002; 
Beltcheva et al., 2001; Aya et al., 2000; Bolk et al., 1999; Gigante et al., 2002). Interestingly, cell 
culture studies have shown that most mutant nephrin proteins become trapped in the endoplasmic 
reticulum and do not reach the podocyte cell surface (Liu et al., 2001). This explains the severe 
phenotype of many NPHS1 patients with missense mutations.  
 
3.2 Focal and segmental glomerulosclerosis (FSGS) 
 
FSGS accounts for 4 to 8 % of the children with primary NS. The incidence in Finland is lower than 
elsewhere, approximately 2% (Koskimies et al., 1982). In light microscopy, the glomeruli show 
segmental acellular sclerosis (Gusmano et al., 2004). Loss of foot processes affecting nonsclerotic 
areas of the glomerulus is seen in EM. In addition, detachment of the podocytes from the GBM has 
been reported in kidneys of adult patients with FSGS (Grishman and Churg, 1975). The clinical 
features of FSGS include proteinuria, hematuria, hypertension, resistance to corticosteroid therapy, 
and progression to end stage renal failure. There are, however, varying clinical courses and some 
patients respond to steroid treatment.  
 
Both acquired and inherited forms of FSGS have been reported. The acquired forms often lead to 
terminal renal failure in a few years, but the etiology and pathogenesis are still unknown. Most of 
the patients with familial FSGS show autosomal recessive inheritance and in these cases the disease 
is often caused by mutations in the podocin gene (NPHS2) (Boute et al., 2000). NPHS2 is located 
on chromosome 1q25-31. More than 30 different NPHS2 mutations distributing through the entire 
gene have been identified in these patients (Caridi et al., 2001; Caridi et al., 2003; Winn, 2002). In a 
recent report, a total of 179 children with sporadic NS were screened for NPHS2 mutations: 120 
with steroid resistance, and 59 with steroid dependence/frequent relapses (Caridi et al., 2003). 
Fourteen steroid-resistant patients presented homozygous mutations that were associated with early 
onset of proteinuria. Renal biopsy was available for twelve of these patients, and nine of them had 
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FSGS; two children presented MCNS and mesangial proliferation with IgM deposits. Weber and 
coworkers performed NPHS2 mutation analysis in 338 patients from 272 families with SRNS: 81 
families with autosomal recessive SRNS, 172 patients with sporadic SRNS, and 19 patients with 
diffuse mesangial sclerosis (DMS). The mutation detection rate was 43% for familial autosomal 
recessive and 10.5% for sporadic SRNS, confirming genetic heterogeneity in SRNS.  
 
In some families, the dominant form of FSGS is caused by a mutation in ACTN4 gene located at 
19q13. It encodes α -actinin-4, an actin binding protein localizing to podocyte cytoskeleton (Kaplan 
et al., 2000). The mutant α-actinin-4 binds actin filaments more strongly than the normal protein 
and forms aggregates, which causes a gradual damage in the podocytes (Yao et al., 2004). 
Mutations in ACTN4 are not the only cause of autosomal-dominant form of steroid resistant NS 
(SRNS). Another dominant form of FSGS locus has been mapped to chromosome 11q21-q22 
(Winn et al., 1999). This gene, however, has not so far been identified.  
 
 
3.3 Minimal change nephrotic syndrome (MCNS) 
 
MCNS is the most common form of the NS in children, with an incidence of two to seven per 
100,000 children (Eddy and Symons, 2003; Grimbert et al., 2003; Cunard and Kelly, 2002). The 
term refers to minor changes seen in kidney biopsy as studied by light microscopy. The glomeruli 
may also show some increase in mesangial cells and matrix (Churg et al., 1970). Another 
characteristic feature is the responsiveness to corticosteroid therapy, and the terms ”steroid 
responsive” and ”steroid sensitive” NS are often used (ISKD, 1981 a). Indeed, 85% of patients will 
recover in four weeks of corticosteroid treatment. However, MCNS tends to run a relapsing course, 
and only 30% of children have a single episode (Hodson et al., 2005; Niaudet, 2004). In addition, 
some patients with MCNS do not respond to steroids and also other histopathologic findings are 
seen in some steroid sensitive patients (ISKD, 1981 b). 
 
Since 1960´s, standard prednison regimens have been used to treat the nephrotic episodes in MCNS. 
The regimen consists of prednisone in a dosage of 60 mg/m2/day for 4-6 weeks, followed by a 
dosage of 40 mg/m2/every other day for another 4-6 weeks (Bargman, 1999; Hodson et al., 2005). 
On average, disappearance of proteinuria occurs in 10 to 14 days, but there are also patients 
responding clearly later. If the remission is achieved after four weeks of steroid therapy, the patient 
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is defined as a late responder. Those not responding after four weeks on the initial corticosteroid 
regimen are considered steroid resistant. Alkylating agents (cyclophosphamide, chlorambucil), 
cyclosporine A (CsA), and levamisole are used in steroid resistant and in refractory steroid sensitive 
cases (Habashy et al., 2004).  
 
3.3.1 Pathogenesis 
 
The etiology of MCNS is unknown. Traditionally, MCNS has been grouped under the heading of 
idiopathic nephrotic syndromes. It is still not known, whether MCNS and FSGS present two 
separate disease entities. In general, MCNS is considered as a primary disorder of the immune 
system. MCNS was associated with an abnormal T-cell response already in 1970´s (Van Den Berg 
et al., 2002; Grimbert et al., 2003). In addition, many disorders associated with MCNS have an 
immunological basis including atopy, autoimmune diseases and lymphomas (Yap et al., 1983; 
Meadow et al., 1981; Eddy and Symons, 2003). Activation of Th2 helper cells and production of 
cytokines, such as IL-13 and IL-4, occur both in MCNS and allergic disorders (Yap et al., 1999). 
Also, “non-allergic” involvement of T-cells and various cytokines in the pathogenesis of MCNS has 
been suggested (Lin and Chien, 2004; Eddy and Symons, 2003). Despite reported differences 
between cytokine expression profile and function of lymphocytes in relapse versus remission, the 
link between the immune system and MCNS has remained obscure (Lama et al., 2002; Cunard and 
Kelly, 2002). 
 
3.3.2 Clinical features 
 
MCNS manifests usually between the ages of 2 and 6 years (Churg et al., 1970; White et al., 1970). 
Boys are more commonly (2:1) affected than girls. The onset is often associated with an infection, 
but the mechanism behind this is unknown. Most of the children are normotensive and have normal 
serum creatinine values. Usually urinalysis reveals only proteinuria, but some patients may also 
have occasional hyaline or waxy casts and hematuria. Renal biopsy is performed before the 
corticosteroid treatment, if the clinical features suggest a diagnosis other than MCNS, or later, if the 
child fails to respond to steroid therapy.  
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MCNS has a tendency to relapse (Nanjundaswamy and Phadke, 2002). Relapses respond usually 
well to corticosteroids, but a few patients (1-3%) regarded as steroid sensitive develop later steroid 
resistance (late non-responder)(Niaudet, 2004). Approximately 70% of the Finnish children with 
MCNS had recurrences in the study of Koskimies et al. (Koskimies et al., 1982). Of those who 
relapse, approximately half have frequent relapses (more than two relapses in six months or four or 
more relapses in any one year) or become corticosteroid dependent (Lewis et al., 1989; Koskimies 
et al., 1982). Steroid dependency is defined as two consecutive relapses, which occur during the 
corticosteroid treatment, or within 14 days after its cessation. Prolonged high-dose corticosteroid 
therapy in steroid dependent and frequently relapsing patients may cause significant side effects, 
which can be ameliorated by using cyclophosphamide or cyclosporine. The tendency to relapse 
declines with age, and most children outgrow this disease by their late teens with no permanent 
damage to their kidneys. A strong chance of a long-term remission is considered if a nephrotic child 
has been free of relapses for five years.  
 
Complications of MCNS include infections and thrombosis (Cameron, 1987). Susceptibility to 
infections of bacterial origin such as streptococcus pneumoniae may be a consequence of the 
immunosuppressive therapy and decreased immunoglobulin levels. The risk of arterial and venal 
thrombosis is increased in nephrotic children due to the hypercoagulable state that results from 
relative hypovolemia with high levels of fibrinogen and low levels of antitrombin III. The estimated 
risk of thrombosis is quite low being about 3%, but must be taken into consideration especially 
when there are other coexisting problems such as fever, vomiting or diarrhea, which may further 
reduce the intravascular volume (Niaudet, 2004). 
 
3.3.3 Long term outcome 
 
MCNS has the best prognosis of all NS kidney disorders, with 90% of all patients responding to 
treatment. Based on the follow-up studies mainly performed in the 1980´s, the overall outcome of 
MCNS is regarded as favorable. In 1980´s, three series of patients with a biopsy proven MCNS 
were published (Koskimies et al., 1982; Trompeter et al., 1985; Lewis et al., 1989). The follow-up 
time ranged from five to 21 years so that the oldest patients were young adults at the time of the 
analysis. From 5 % to 19% of the patients were reported to have nephrotic episodes in adulthood. 
The studies, however, contained relatively few adult patients. More recently Fakhouri and co-
workers (Fakhouri et al., 2003) reported the outcome of 102 MCNS patients who were on average 
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26-28 years old at the time of evaluation. Up to 42% of their patients were found to experience at 
least one relapse in adulthood, which was clearly more than expected from the older reports. The 
high percentage was most probably due to the patient selection, since they studied mainly steroid 
dependent patients. Even if the clinical course may stretch over many years, the majority of the 
patients continue to have a normal renal function also in adult life. 
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 AIMS OF THE STUDY 
 
The aim of this research was to investigate the pathophysiology, outcome, and prognostic factors of 
minimal change nephrotic syndrome (MCNS), which is the most common pediatric kidney disease. 
The specific aims were: 
 
1 To study the ultrastructure of podocytes, podocyte slit pores, and slit diaphragms in MCNS 
kidneys using different electron microscopy techniques.  
 
2. To evaluate the role of genetic variants of the major podocyte slit diaphragm proteins, nephrin, 
podocin, CD2AP and Neph1 in the pathophysiology of MCNS.  
 
3. To analyze the clinical features, risk factors, and long-term outcome of MCNS in a national 
cohort of MCNS patients.  
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MATERIALS AND METHODS  
1. Patients (I-IV) 
 
A total of 127 children with primary nephrotic syndrome were examined and treated at Hospital for 
Children and Adolescents, University of Helsinki, during 1965-1981. MCNS was diagnosed in 111 
children and the long-term data could be attained from 104 individuals (IV). The diagnosis of 
MCNS was based on clinical data and renal histology (I- IV). In addition, biopsy material from ten 
patients with tubulointerstitial nephritis (TIN), five patients with membranous nephropathy (MN), 
and eight patients with NPHS1 were used in the structural analyses of kidney glomerulus (I, II). 
Their diagnoses were based on the clinical data and the histopathology of the kidney biopsies. The 
diagnosis of NPHS1 was verified by analysis of the NPHS1 gene (I, II). Additional controls 
included six biopsy samples that were obtained from patients with no proteinuria (II). These 
patients underwent control renal biopsy because of having a renal transplant (three cases), or a liver 
transplant (three cases). A total of 38 adult MCN patients with a clinical disease of variable severity 
were selected for the analysis of the SD genes (III, IV). Controls included 50 young adults with no 
personal or family history of kidney diseases (III, IV). The patients were all of the Finnish origin (I-
IV). 
 
2. Collection of clinical data (I-IV) 
 
Clinical data were carefully recorded from the hospital records. For the analysis of the outcome of 
MCNS (IV), questionnaires were mailed to verify the present health status of the participants. 
Additional information was obtained by contacting the individual by phone. Also, data were 
received from the patient’s general practitioner or local hospital. Forty-five patients visited the 
Hospital for Children and Adolescents in Helsinki and underwent a clinical examination. A written 
informed consent was obtained from all study participants.  
 
3. Tissue and blood samples (I-IV) 
 
Renal tissue blocks for EM were obtained by core needle biopsies taken on clinical indications from 
patients treated during the years 1969-2003 at the Hospital for Children and Adolescents, University 
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of Helsinki (I, II). This material was completed with biopsies taken from patients during the years 
2001-2003. Kidney samples from nonproteinuric patients with TIN (10), renal transplant (3), and 
liver transplant (3) were collected and used as controls. Blood samples for the DNA analyses were 
collected from a total of 80 patients with MCNS (III, IV). A total blood count, electrolytes, serum 
creatinine, albumin, cholesterol and triglyseride values were measured from seventy seven 
participants visiting the laboratory at our hospital or their local health centres (IV).  
 
4. Transmission electron microscopy (TEM) (I, II) 
 
The preparation of the renal biopsies for EM was performed according to standard procedures. The 
tissue blocks were fixed by 2.5% glutaraldehyde and embedded in Epon. Ultrastructural evaluation 
of the SDs was performed with TEM by calculating the proportion of the slit pores with detectable 
SD. One to three glomeruli were evaluated from each sample with a Jeol 1200 EX electron 
microscope at 60kV (I, II). The ”empty” slit pores were re-evaluated by performing a tilt series of 
the section so that a minimum of 20 slit pores with no detectable SD were analyzed. 
 
For the analysis of the podocyte structure and podocyte adhesion to GBM, each sample was 
sectioned in series so that ten grids were collected from levels that were 1.2 µm apart from each 
other (II). Five to ten different capillaries were studied from each glomerulus with an FEI Tecnai 
F12 electron microscope at 80 kV. The analysis of the podocyte pores was performed at a 
magnification of 8200. All areas suspected to show denuded GBM were photographed for further 
inspection. 
  
5. Scanning electron microscopy (SEM) (II) 
 
The glomeruli for SEM were isolated under the dissection microscope immediately after the 
biopsies. The samples were fixed with phosphate buffered glutaraldehyde 2.5% (w/v) for two hours. 
Some samples were also treated with 1% (w/v) osmium tetroxide. After washing in phosphate 
buffer the samples were dehydrated in a series of graded ethanol dilutions. Finally, critical point 
drying with liquid carbon dioxide was performed using the Bal-Tec CDP 030 critical point drying 
unit. The samples were mounted under a microscope on aluminum stubs with double-sided tape and 
silver glue, and then sputter coated with platinum or chromium. The specimens were observed using 
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both Zeiss scanning electron microscope DMS 962 and a Jeol field emission scanning electron 
microscope JSM 6335F.  
 
6. Immunoelectron microscopy (II) 
 
For cryosectioning, biopsy samples were fixed in phosphate buffered 3.5% paraformaldehyde and 
0.02% glutaraldehyde. After fixation and washing the samples were embedded in 10% gelatin, 
infiltrated with 2.3 M sucrose in PBS and frozen in liquid nitrogen. Immunolabeling was done by 
Tokuyasu method (Tokuyasu and Singer, 1976; Liou et al., 1996). About 70 nm thick sections were 
labeled for 60 min with anti-nephrin, and then incubated with fresh protein A coupled to 10-nm 
gold for 30 min. Polyclonal rabbit anti-nephrin antibody against the intracellular domain of nephrin 
was used (Ruotsalainen et al., 2000). Protein A-gold conjugate was purchased from University of 
Utrecht, School of Medicine, Department of Cell Biology. Sections were observed in an electron 
microscope (Tecnai F12, FEI, Eindhoven, Holland) and photographed for detailed analysis.  
 
7. Genetic analysis (III, IV) 
 
The genomic DNA was isolated according to standard laboratory procedures from frozen or fresh 
peripheral blood samples obtained from MCNS patients and controls. The isolation was performed 
using conventional molecular biology technique (Puregene EPTM DNA Purification Kit, Gentra 
Systems). The analyses of protein coding regions of genes encoding for nephrin (29 exons), podocin 
(8 exons) , NEPH1 (12 exons) and CD2-AP (18 exons) were performed using direct sequencing. 
Exons were amplified by PCR with flanking intron primers designed for exons and the reactions 
were performed in total volumes of 25 µl as previously described (Lenkkeri et al., 1999). The 
sequencing was performed on DNA-samples from 38 MCNS patients with varying severity of the 
disease. In addition, NPHS1 exons 2 and 26 were screened for Fin-major and Fin-minor mutations 
from a total of 80 patients. The significance of a nucleotide change was controlled by sequencing 
the same exon in DNA-samples from 25-50 healthy controls.  
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8. Statistical analysis (I-IV) 
 
The EM findings were analyzed with Mann-Whitney U test. Student T-test was used to analyze the 
difference in the mean number of allelic variants between patients and controls.  
In the clinical data the outcome variables were dichotomous, and consequently logistic regression 
was used to determine odds ratios with 95% confidence intervals for the effects of each predictor 
variable on these outcomes. T-tests were used to compare background clinical data between groups. 
Calculations were done on a PC using SPSS 11.0 software (SPSS Inc, Chicago, IL, USA).  
 
9. Ethical issues 
 
All the studies were approved by the Ethics Committee of the Hospital for Children and 
Adolescents, University of Helsinki (509/E7/2001).  
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RESULTS  
1. Ultrastructure of glomerular capillary wall in proteinuric kidneys (I, II) 
1.1 Podocyte structure (II) 
 
The overall structure of the glomerular capillary wall and podocytes in control and proteinuric 
kidneys were evaluated by SEM. In the control kidneys podocytes formed a well-preserved 
organization with primary, secondary and tertiary processes, as shown in Figure 7. In NPHS1 
glomeruli with massive proteinuria, the podocyte cell bodies were prominent and had a balloon-like 
appearance. Often only one primary process connected the cell body to a flat cytoplasmic sheet with 
no branching (Figure 7). These epithelial plates with narrow cell borders usually covered the major 
part of the capillary wall. Variation in the appearance, however, was evident, and in some areas 
primitive ramification or slender processes with filamentous connections were observed. Especially 
in NPHS1, there were also occasional lumpy protrusions of the cytoplasm, which aggregated on the 
surface of the podocyte foot processes.  
 
 
Figure 7. SEM micrographs of TIN (A), MCNS (B), and NPHS1 (C) kidneys. A) A normal 
capillary loop in a control patient (TIN) shows organized branching of the epithelial processes. B) A 
capillary loop in proteinuric MCNS patient. The podocyte cell body is marked with an arrow. 
Epithelial processes are observable but clearly less organized. C) A capillary loop in a NPHS1 
patient shows slender primary process, which gives the podocyte cell body (arrow) a balloon-like 
appearance. 
 
The organization of podocyte processes in MCNS glomeruli was, in general, not as severely 
affected as in NPHS1 (Figure 7). Branching of the primary processes was present in some areas. 
Also, foot processes could be recognized, but they were disorganized and had a thin and a flattened 
appearance. 
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 1.2 Podocyte foot processes (II) 
 
Effacement and attachment to GBM. The effacement of the podocyte foot processes was evident in 
all proteinuric MCNS and NPHS1 kidneys, and also in samples from the three MCNS patients who 
had been in remission from five days to four months. The attachment of the podocytes to the GBM 
was analyzed by SEM and TEM in kidney samples from patients with MCNS and NPHS1. In SEM, 
no areas of denuded GBM or holes in the epithelial cell covering were observed either in the 
NPHS1 or MCNS glomeruli. The epithelial cell layer in the NPHS1 kidney contained occasional 
balloon-like spaces, which, however, were located intracellularly and not between the podocyte and 
the GBM. The epithelial covering varied in thickness, which partly resulted from the angle of a 
cross-section in the EM study. Two MCNS glomeruli had a small area of denuded GBM at the edge 
of the section where capillaries were easily subjected to distension during the preparation of the 
sample.  
 
Endocytic activity. To asses the endocytic activity in the podocytes, the number of membranous 
invaginations (coated pits) at the basal and apical surface were counted in TEM. These 
invaginations were seen in all samples and both in areas with effacement and in the areas where 
podocytes showed normal architecture. No clear difference in the frequency of coated pits was 
found between proteinuric and non-proteinuric kidneys.  
1.3 Podocyte slit pores (I, II)  
 
Due to the foot process effacement the density of the podocyte slit pores (number of slits per 
underlying GBM length) was decreased from 1542 pores/mm of GBM in controls to 308 pores/mm 
in NPHS1, and to 478 pores/mm in proteinuric MCNS kidneys. Pore density was reduced also in 
nonproteinuric patients with MCNS. One patient, who had been in remission for four months, still 
had slit pores only about half (0.87 pores /mm) of the normal (1.5 pores /mm). 
 
The glomeruli studied by TEM contained a total of 3445 podocyte slit pores. In proteinuric kidneys, 
the width of a slit pores showed a large variation and was occasionally increased up to 50-80 nm. 
However, more often the slit pores looked quite narrow and, in highly proteinuric NPHS1 
glomeruli, almost half of the pores (47%) were so “tight” that no visible slit between adjacent foot 
processes was seen (Figure 8). Pores were classified as “tight” or “closed” if there was only a 
 39
narrow space (5-10 nm) or no visible space between the membranes of the neighboring foot 
processes. This observation was partly dependent on the angle of the cross-section, since 20 % of 
the pores looked tight also in control kidneys. In MCNS, the proportion of the “tight” or “closed 
“slit pores varied from 19 to 66%.  
 
 
Figure 8. Normal podocyte architecture with filtration slits and SDs (arrowheads)(A). Broad 
epithelial sheets with basal invaginations (arrowheads) and narrow podocyte pores (arrows) in a 
nephrotic patient with NPHS1 (B) and in a nephrotic patient with MCNS (C). Capillary wall in 
remission phase of MCNS showing also normal-width pores (arrowheads)(D). 
 
 
The analysis also revealed that 13,7% of the pores in NPHS1 glomeruli had diffuse filamentous 
material. In MCNS, such material was seen in 3,4% (relapse) and 5,6% (remission) of the slits, 
which is more than in controls (0,9%). However, the results were diverse within MCNS patients and 
due to the limited number of cases, no statistical difference could be verified. 
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 1.4 Slit diaphragm (I) 
 
The podocyte slit pores were systematically evaluated by TEM. The proportion of the pores with a 
visible SD was counted. The linear image of the SD was not detectable in every pore due to the 
variable angle of the slit cross-section. Since the visibility of the SD was dependent on the angle of 
the cross-section, the second analysis was done by tilting the section. This tilt series from –45 to 
+45 was performed on the pores where the SD was first undetectable.  
 
Kidneys with TIN showed normal ultrastructure of the glomerular capillary wall with regular 
filtration pores. The SD was first observed in only 54% (487/902) of the filtration slits studied in 
eight samples with TIN. The tilting analysis revealed a linear SD in 125 of the 176 (69%) pores 
analyzed.  
 
In MCNS, the broad epithelial sheets covered the GBM and irregular sized foot processes were 
present. The percentage of the pores with a detectable SD varied from 24% to 41% (median 34%, 
1265 slits evaluated) in the eleven MCNS samples. The proportion of the pores with the SD was 
reduced by 39% in MCNS kidneys compared with the TIN kidneys (p=0.0003). The tilting analysis 
revealed the SDs in 26% (59/228) of the slits analyzed, which was also significantly less than in 
TIN kidneys (p=0.0003). In addition, junctions with ladder-like structures were observed in four of 
the 11 MCNS glomeruli. These were detected in the intercellular space of podocytes close to the 
GBM, as has been described in immature glomeruli (Ruotsalainen et al., 2000).  
 
 
In kidneys with MN, similar effacement of podocyte foot processes was seen as in MCNS. The 
number of MN podocyte pores with detectable linear images of the SD varied between 38 and 56% 
(median 45%, 585 slits evaluated) in the standard analysis. This was less than in TIN kidneys 
(median 54%) but difference was not statistically significant (p=0.09). By tilting the linear image of 
the SD could be visualized in 68% (71/105) of the podocyte pores where it originally was 
undetectable, which was comparable to that in TIN kidneys (71%). In addition, junctions with 
ladder-like structures were found in three of the five MN glomeruli.  
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In TEM, narrow slit pores with filamentous material were predominantly seen in proteinuric 
kidneys. Immunoelectron microscopy of the MCNS glomeruli showed that nephrin was located at 
the apical part of the filamentous material in these narrow slit pores (Figure 9 B,C). In wider pores 
(Figure 9A), nephrin was seen at the level of the filamentous material either in the apical region of 
the foot process or at the “right” level above the GBM (II).  
 
 
 
Figure 9. Immuno-EM for nephrin. Nephrin labeling in the remission (A) and in the relapse phase 
of MCNS (B,C). In proteinuric MCNS kidneys, nephrin is seen mostly in the apical parts of the 
narrow slit pores. 
 
 
2. Genetic variants of podocyte proteins in MCNS (III, IV) 
2.1 Nephrin gene (NPHS1) 
 
Direct sequencing of the 29 NPHS1 exons were performed on DNA-samples obtained from 38 
patients with MCNS of different severity. A total of 13 sequence variants were observed in 11 
exons. Six of the 13 nucleotide changes were known polymorphic variants (SNP). Three of these 
caused an amino acid substitution, and three had no effect on the amino acid sequence of nephrin. 
Nucleotide changes were especially common in exons 3 and 26. The significance of these changes 
was examined by sequencing the same exons from the DNA of 25-50 control subjects, and 
comparing the results to the published data (Lenkkeri et al., 1999; Beltcheva et al., 2001; Bolk et 
al., 1999; Aya et al., 2000) and public databases (dBSNP, SNPper). While Fin-major mutation in 
exon 2 was observed in one MCNS patient, none of the patients had Fin-minor mutation in exon 26. 
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 No homozygous mutations were observed in MCNS patients. However, seven of the 38 MCNS 
patients had five different heterozygous allelic variants in the nephrin gene leading to non-
conservative amino acid substitutions not previously reported (G879R; R800C; T294I; A916S; 
S1058L). In addition, two of the seven patients had heterozygous nucleotide variants resulting in 
conservative amino acid substitution (A342G; S786N). Thus, these seven MCNS patients had a 
total of nine heterozygous nucleotide variants resulting in amino acid changes of nephrin protein. 
There were seven different amino acid changes, six of them previously unreported. In addition, six 
polymorphic variants were detected. NPHS1 alterations found in MCNS patients are summarized in 
Figure 10. 
 
Patient no 1 had a nucleotide change of 2635G>A in exon 19 causing a substitution of neutral 
glycine by positively charged arginine (G879R) at a conserved site of Ig-8 domain, and a nucleotide 
change 2357G>A in exon 18 causing a conservative amino acid substitution of serine by asparagine 
(S786N) at a non-conserved site of Ig-7 domain. He had 18 proteinuric episodes in childhood. After 
18 years of remission, one relapse occurred in adulthood. The mother of this patient carried only the 
substitution G879R, suggesting that the two variants in this patient were in different NPHS1 alleles.  
 
Patient no 2 had a 2398C>T change in exon 18 leading to a substitution of basic arginine by 
cysteine (R800C) at a conserved site in the Ig-7 domain and a 1025C>G transition in exon 9, 
causing a conservative amino acid substitution of alanine by glycine (A342G) at a conserved site 
between motifs Ig-3 and Ig-4. She responded poorly to steroid treatment. Both parents of this 
patient had deceased and no DNA material was available for the analysis of the allelic variants. The 
R800C-substitution was found in a heterozygous form in one of the 35 controls.  
 
Patient no 3 had a Fin-major mutation in exon 2 leading to a truncated nephrin peptide of only 90 
amino acids, and the same nonconservative R800C substitution in Ig-7 domain as patient no 2 and 
patient no 7. The initial proteinuric episode at the age of seven years responded poorly to steroids 
(early non-responder) but the four relapses were successfully treated with prednisone. At the age of 
40 years the patient was doing clinically well with a slightly elevated serum creatinine value (126 
umol/l). The creatinine clearance (as calculated according to the Cockcroft-Gault formula) was 80 
ml/min. The analysis of DNA sample from the mother of this patient revealed that he carried only 
the nucleotide change R800C suggesting that the two variants in the patient were in different alleles. 
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Because the father of this patient had deceased and no DNA-sample was available, a de novo 
mutation (Fin-major) could not totally be excluded.  
 
Patient no 4 had a nucleotide change of 881C>T in exon 8 causing a substitution of hydrophilic 
threonine by neutral isoleucine (T294I) at a non-conserved site in Ig-3 domain, and a nucleotide 
change of 3230A>G in exon 24 leading to a known polymorphic amino acid substitution of 
asparagine by serine (N1077S) in transmembrane part of nephrin polypeptide. Interestingly, this 
patient had transient proteinuria in infancy before MCNS started at the age of five years. The 
T294I- substitution has previously been reported in a mother of a NPHS1 child and has been 
regarded as a polymorphic change (Beltcheva 2001).  
  
Patient no 5 had a single change of 2746G-T in exon 20 resulting in a substitution of hydrophobic 
alanine by hydrophilic serine (A916S) at a conserved site in Ig-8 domain. The patient had 13 
relapses in childhood. As an adult she had a calculated creatinine clearance of 63.1 ml/min but no 
diagnosed kidney disease. Patient no 6 had a single nucleotide change 3173C-T in exon 24 causing 
a nonconservative amino acid substitution of serine by leucine (S1058L) at a conserved site of the 
transmembrane domain. The patient had experienced four nephrotic episodes during her adult life. 
Patient no 7 carried a nonconservative R800C substitution in Ig-7 domain. He had a single 
nephrotic episode in childhood. 
 
 
 
Figure 10. The NPHS1 alterations found in MCNS patients. In addition to six polymorphic variants 
seven allelic variants leading to amino acid changes of nephrin protein were found.  
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2.2 Podocin, Neph1 and CD2AP genes 
 
Direct sequencing of genes coding for podocin, NEPH1, and CD2AP were also performed on DNA-
samples from 38 MCNS patients. The major finding was that no homozygous mutations were 
detected in any of the three genes. CD2AP was highly conserved and no polymorphic changes were 
found. Similarly, no mutations in NEPH1 were observed and only three polymorphic changes in 
exons 4,8,13 could be identified. In podocin gene (NPHS2), E87K substitution was found in one 
patient (patient no 1), but not in any of the controls. This patient had also two heterozygous amino 
acid changes of nephrin (G879R; S786N). Heterozygous R229Q substitution was detected in four of 
the MCNS patients (10%) and in 5 of the 51 controls (10%). One of the four patients had also 
change in his nephrin gene (patient no 4). In addition, five polymorphic variants were found in 
NPHS2 gene both in the study subjects and in controls.  
 
Table 1. Total number of different amino acid substitutions and polymorphic changes found in SD-
proteins in 38 patients with MCNS. 
 
Gene Amino acid substitutions Polymorphisms 
NPHS1 7 6 
NPHS2 2 5 
NEPH1 - 3 
CD2AP - - 
 
 
 
3. The course and prognostic factors of MCNS (IV) 
 
A total of 111 children with MCNS were examined and treated at Helsinki University Children’s 
Hospital during 1965-1981. Long-term data were attained from 104 individuals, and they were 
followed for a mean of 30 years (range 21-38 years) (Table 1). Seventy-four (71%) of the patients 
were males. The mean age at onset of MCNS was 5.0 years and the disease lasted on average 4.7 
years (1 month to 33 years). While 23 patients (22%) experienced only a single episode, the 
remaining 81 patients had 1-28 (median 3) relapses during childhood (Table 2). 
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Fourteen patients (13.5 %) had proteinuria also as an adult (=> 18 years of age). Three of them had 
occasional proteinuria without clinical manifestations. Three subjects were constantly more or less 
proteinuric and had been under continuous prednisone treatment for several years. Eight subjects 
had experienced a total of 15 nephrotic episodes as an adult (mean 1.9, range 1-4). The latent period 
between the childhood and adulthood episodes varied from two to 17 years and the interval between 
the adulthood episodes was on average 4.6 years (range 1-11 years). As compared to those with 
only a childhood disease, the subjects with proteinuria as an adult had a tendency for a more 
complicated disease already in childhood: They had more often >10 childhood episodes (57% vs. 
11%, OR 9.6 (2.8 to 32.8) p=0.0003), were more often steroid dependent (57% vs. 10%, OR 12.0 
(3.4 to 42.4), p=0.0001), and needed more often cytostatic drugs (71% vs. 35%, OR 3.9 (1.1 to 
13.5), p=0.03) (Table2). 
 
The patients were on average 35 years (range 25-44 years) at the last follow-up. Although a portion 
of them had proteinuria and autoimmune-type other diseases, their health status was generally good 
despite of severe childhood illness. The mean plasma creatinine level was 82.1 µmol/l, range 52-
126 µmol/l. Except for those 14 individuals with continuing proteinuric episodes, no one had been 
diagnosed for a renal disease as an adult. However, plasma creatinine levels exceeded slightly the 
reference values (<95 µmol/l for men, <90 µmol/l for women) in 13 subjects. In 12 of these 13 
patients, creatinine clearance was between 80-108 ml/min. One female had a creatinine clearance of 
63 ml/min. Allergic symptoms and asthma were diagnosed in 17% and 6.7%, respectively. The 
prevalence of insulin treated diabetes was 4.2% in patients under the age of 35 and 5.4% in patients 
over 35 years of age. Three patients (2.9%) had ulcerative colitis (vs 0.9% in the Finnish 
population). One of them had a combination of ulcerative colitis, psoriasis and diabetes. Seven 
percent were obese (BMI >=30 kg/m2) and 7.6% needed antihypertensive medication. While one 
participant was treated for hypercholesterolemia, the mean cholesterol level in the study cohort (4.7 
mmol/l, range 2.4-6.5 mmol/l) did not exceed that in the general Finnish population (Finnriski 
2002). Nobody had suffered from cancer. 
 
Over half (58%) of the participants had children. Subjects treated with prednisone alone (59 
subjects) and those treated also with cytostatic drugs (45) in childhood had on average 1.4 and 1.2 
children, respectively (95% confidence interval for difference –0.4 to 0.8, p=0.4). None of the 122 
children or other first degree relatives (siblings, parents) had nephrotic syndrome. Temporary 
proteinuria was reported in four first-degree relatives. 
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Possible predictors for severe childhood disease or adulthood proteinuria were evaluated (IV). 
Mesangial hypercellularity in kidney biopsy, male sex, young age at the onset of the disease, and 
atopy/asthma in childhood or adulthood were not statistically significant risk factors for a more 
severe disease. Also, all eight subjects with diabetes or other immunological disease as an adult had 
a relatively mild disease in childhood (number of episodes 1-10, mean 3). The precise data on the 
birth weight and gestational age at delivery were available for 52 subjects. Ten of these children had 
a birth weight below the 10th percentile, however neither this nor birth weight standard deviation as 
a continuous variable predicted a more serious MCNS.  
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DISCUSSION 
 
Understanding of the pathogenesis of proteinuria is of great importance both in pediatric and adult 
nephrology. During the past decades, several theories have been offered to explain the leakage of 
plasma proteins into urine in nephrotic kidney diseases. Proteinuria has been suggested to result 
from: 1. Defects in the GBM. The reduction of proteoglycan content of the GBM leading to 
diminished anionic charge, has especially been regarded important (Raats et al., 2000; Vernier et 
al., 1983), 2. Detachment of the podocyte foot processes and formation of denuded areas of the 
GBM (Whiteside et al., 1989; Yoshikawa et al., 1982; Regele et al., 2000). 3. Defects in the SD 
connecting the podocyte foot processes (Rodewald and Karnovsky, 1974).  
 
The recent breakthroughs in podocyte biology have clearly indicated that nephrotic diseases are 
coupled with defects in the structure or function of the podocytes. To date, also MCNS is suggested 
to involve dysfunction of the glomerular podocytes (Eddy and Symons, 2003; Grimbert et al., 
2003). This has been thought to result from an interference of podocyte with some kind of a 
circulating factor (Garin, 2000). However, no such permeability-modifying factor has so far been 
isolated and actually all the evidence for immune mechanisms in MCNS is indirect. The role of 
podocytes is supported by the fact that the only detectable abnormality in MCNS is the effacement 
of the podocyte foot processes seen in electron microscopy.  
 
Interestingly, recent works have pointed out that podocytes express receptors for interleukins (Parry 
et al., 2001), chemokines (Huber et al., 2002), and complement proteins including C3 (Sacks et al., 
1993). Since the cytokines are shown to affect the function of podocytes (Parry et al., 2001; Van 
Den Berg et al., 2002) and podocytes are clearly capable of responding to various soluble products 
of the immune system, it can be speculated whether the podocyte is a victim or the one to blame. 
However, this raises at least two important questions: what are the targets in the podocyte, and 
subsequently the final pathway for leaking proteins. 
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1. The ultrastructure of the glomerular capillary wall (I, II) 
1.1 Podocyte attachment and pinocytic activity 
 
A major observation in the present EM studies was, that no epithelial cell detachment or formation 
of areas of denuded GBM were present either in the proteinuric MCNS or NPHS1 kidneys (II). 
Indeed, the extensive search for such areas in SEM and TEM revealed only two small patches of 
bare GBM in two MCNS kidneys (one in relapse and the other in remission). The possibility, that 
focal epithelial gaps may have been missed, must be taken into consideration, since the tissue 
sections analyzed represent only a small portion of the kidney. However, in order to obtain maximal 
coverage we used sections that were taken 1 µm apart. In animal models the denuded areas have 
been quite numerous: one gap in every fifth section (Whiteside et al., 1989). Thus, the 200 sections 
analyzed from the 10 proteinuric MCNS glomeruli in our work should have contained about 40 
gaps - instead of one small area in the edge of a section. This suggests that while gaps may be a 
frequent finding in PAN, this is not the case in MCNS.  
 
Also, the kinetics of the foot process alterations speak against the detachment-theory. In MCNS, 
proteinuria typically resolves within a few days after commencement of prednisone therapy whereas 
the podocyte lesions normalized very slowly (within months). Thus, the rapid response is more 
easily explained by molecular reorganization of podocyte proteins rather than healing of the 
possible epithelial gaps.  
 
The hypothesis that proteinuria is linked to the endocytotic activity of podocytes was also tested. 
The suggestion that proteins might pass through the epithelial cells into urinary space via 
cytoplasmic vesicles and vacuoles, is based on EM- and tracer-studies especially in rats with PAN 
nephrosis (Trump and Benditt, 1962; Venkatachalam et al., 1970; Farquhar et al., 1961; Inokuchi et 
al., 1996). Also, the NS resulting from deficiency of CD2AP has been suggested to be associated 
with a defect in the podocytic endocytosis (Kim et al., 2003). Based on these data, the endocytic 
activity of podocytes was evaluated in NPHS1 and MCNS kidneys by counting the pinocytic 
invaginations in the basal as well as in the apical areas of the cell membrane. The analysis, 
however, showed no difference in the invagination frequency between proteinuric and non-
proteinuric glomeruli, which suggests that endocytosis does not play a significant role in protein 
transport through the capillary wall in NPHS1 or MCNS. 
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 1.2 Podocyte slit pores 
 
Due to the podocyte foot process effacement the number of podocyte slit pores was dramatically 
reduced in proteinuric kidneys (II). The remaining slit pores showed qualitative changes in SEM 
and TEM, so that up to 50 % of the residual slits were “closed” or “tight”. This phenomenon has 
previously been described in human nephrotic kidneys (Folli et al., 1958) as well as in PAN 
nephrosis in rats (Farquhar and Palade, 1961; Venkatachalam et al., 1969; Venkatachalam et al., 
1970; Ryan et al., 1975; Ryan et al., 1975; Caulfield et al., 1976). Based on our survey, the area of 
open slit pores was reduced to 10 % of normal in NPHS1 kidneys and to 23 % in nephrotic MCNS 
kidneys. It is possible that the tight slits restrict normal ultrafiltration. Since neither of these 
diseases is associated with impaired glomerular clearance of water and small solutes, the filtration 
surface of the capillary wall in normal kidneys seems extensive. The narrowing seen in the 
remaining slit pores may point to the presence of alterations in the interactions of SD proteins such 
as podocin, nephrin NEPH1 and CD2AP.  
 
1.3 Slit diaphragm 
 
An important finding was that MCNS kidneys showed a significant reduction of the linear image of 
SDs in the remaining podocyte pores (I). The total proportion of the slits with detectable image of 
the slit diaphragm was only 26% in MCNS glomeruli (vs. 71% in TIN). On the other hand, similar 
effacement of podocyte foot processes was seen in all of the five samples of membranous 
nephropathy (MN) but no statistically significant reduction of the SDs. The fact, that slit pores in 
MN kidneys with proteinuria looked normal, favors the idea that the disappearance of slit 
diaphragm image in MCNS kidneys is not secondary to proteinuria.  
 
The EM findings in MCNS were similar to those in NPHS1, which is characterized by massive 
proteinuria from the birth. In NPHS1 children with severe mutations (Fin-major and Fin-minor), the 
major slit diaphragm component, nephrin, is missing, and podocyte pores are ”empty” (Patrakka et 
al., 2000). These slits might serve as the site for protein leakage in both NPHS1 and MCNS. Since 
the filtration of water and small plasma solutes normally occur through the slit pores (Deen et al., 
2001), it is natural to think that proteins might use the same route if the SD is disrupted.  
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 On the other hand, it is clear that EM is a crude method for studying such a complex protein 
structure as the slit diaphragm, and the association of the EM findings and protein leakage are not 
so strict. Proteinuria may also occur with apparently normal looking SD, which is seen in some 
NPHS1 patients with minor mutations (Patrakka et al., 2000). Also, when anti-nephrin antibodies 
are injected into rats, proteinuria appears in a few hours after injection but the electron microscopic 
findings remain quite normal (Orikasa et al., 1988; Topham et al., 1999). Moreover, three of the 
eight MCNS patients in our study (I) had reached remission four to seven days before the renal 
biopsy and still showed slit pores with no linear image of SD.  
 
Nephrin redistribution from the podocyte slit pores into cytoplasm has been suggested to be one 
potential mechanism of proteinuria in primary acquired NS such as MCNS (Doublier et al., 2001). 
The results obtained from studies on nephrin expression are somewhat contradictory. Nephrin 
expression has been reported to be both normal (Patrakka et al., 2001; Kim et al., 2002; Hingorani 
et al., 2004) and altered in MCNS (Furness et al., 1999; Wernerson et al., 2003; Doublier et al., 
2001). We could not verify cytoplasmic clusters of nephrin in the foot processes, but the 
immunogold labeling of cryosections revealed nephrin more often in the apical parts of the slit 
pores in proteinuric MCNS kidneys than in controls (II). This was clearly seen in the narrow slits of 
the proteinuric MCNS kidneys, which is in accordance with previous findings in rats indicating that 
the SD may move upwards during nephrosis. The reverse changes in the SD position in MCNS 
patients in remission (II) resemble the normal differentiation process occurring in the fetal period 
(Ruotsalainen et al., 2000; Caulfield et al., 1976; Ryan and Karnovsky, 1975). Interestingly, 
junctions with ladderlike structures were also present in MCNS glomeruli (I, II). The ladderlike 
structures are believed to represent a primitive form of the SD and are found both during normal 
glomerulogenesis and in PAN nephrosis in rats (Ruotsalainen et al., 2000; Ryan and Karnovsky, 
1975; Schneeberger and Grupe, 1976). Based on the presence of these premature structures and 
reverse changes in the SD position, it can be hypothesized that they are involved in pathogenesis of 
MCNS.  
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2. Nephrin gene in MCNS (III, IV) 
 
While the precise molecular composition of the SD needs further clarification, the role of nephrin as 
a major component of the SD has been increasingly emphasized (Yuan et al., 2002). In the Finnish 
NPHS1 patients, lack of nephrin leads to massive proteinuria starting from the birth, and 
disappearance of the SD. What could be the role of nephrin in acquired kidney diseases such as 
MCNS? Since the MCNS kidneys were often found to lack detectable SDs, it was hypothesized that 
the patients might have a genetically vulnerable glomerular filter. Due to the central role of nephrin 
in the SD, even a minor defect in it could predispose to proteinuria. Therefore, the possible role of 
this major SD protein was studied by analyzing the nephrin gene (NPHS1) structure in 38 patients 
with a biopsy-proven MCNS.  
 
Searching for mutations in NPHS1 gene, we analyzed a total of 126 chromosomes from MCNS 
patients and controls. We found considerable frequency of allelic NPHS1 variants. A total of 13 
nucleotide changes were observed in 11 exons. Six of the 13 nucleotide changes were known single 
nucleotide polymorphisms (SNP). Three of these caused an amino acid substitution, and three had 
no effect on the amino acid sequence of nephrin. Previously eight exonic SNPs and about 40 
intronic SNPs have been registered in public databases dBSNP and SNPper 
(www.ncbi.nlm.nih.gov/projects/SNP). Five of the exonic SNPs (E117K, P440P, V763V, N1077S, 
S1105S) were found also in our patients. Three reported polymorphisms (T741T, S440S and I98I) 
were not found either in our patients or in the controls.  
 
One of the aims was to study whether the carriership of the Fin-major or the Fin-minor mutation 
would predispose to MCNS (Patrakka et al., 2002). In the Finnish population, the frequency of 
heterozygous Fin-major and Fin-minor carriers is high (about 2%). These carriers have only one 
functional allele, which is normally enough: Parents of the NPHS1 patients do not have proteinuria 
and can be used as donors in kidney transplantation. During fetal period, on the other hand, NPHS1 
mutation carriers have temporary proteinuria indicating the necessity of both alleles for sufficient 
synthesis of nephrin during glomerulogenesis (Patrakka et al., 2002). However, the carrier status of 
these two major mutations did not associate with MCNS, since only one of the 80 MCNS patients 
had heterozygous Fin-major mutation (IV). Thus, it seems that after glomerulogenesis is finished 
one normal allele is enough even in “stress condition” such as MCNS.  
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In essence, the analysis of NPHS1 revealed no specific MCNS-associated mutation. However, 
seven of the 38 patients had heterozygous amino acid substitutions probably leading to unfavorable 
conformational changes in nephrin structure.  
 
One MCNS patient was a heterozygous carrier of the Fin-major mutation. He had also a 2398C>T 
nucleotide change in the other allele causing a substitution of arginine by cysteine in Ig-7 domain of 
nephrin (R800C). MCNS manifested in this patient at the age of seven years and lasted for five 
years. The change of arginine by cysteine (R800C) in Ig-7 domain probably causes formation of 
incorrect disulfide bonds, but otherwise the impact of each amino acid substitution on the protein 
structure cannot, so far, be predicted since the crystal molecular structure of nephrin is not yet 
known. It is, however, interesting that four of the amino acid substitutions in our MCNS patients 
occurred in Ig-7 and Ig-8 domains which show clustering of mutations also in the NPHS1 patients 
(Lenkkeri et al., 1999; Beltcheva et al., 2001).  
 
It is interesting that five Finnish NPHS1 patients have rather similar genetics as the above MCNS 
patient: The Fin-major mutation in one allele and a missense mutation in the other (Lenkkeri et al., 
1999)(Kestilä M, personal communication). Four of these NPHS1 patients have received kidney 
transplantation. However, one girl has the substitution of arginine by cysteine in the spacer area 
close to Ig7-motif (R743C). She had full-blown nephrotic syndrome immediately after birth but 
responded to the anti-proteinuric therapy with indomethacin and ACE-inhibitor and, as yet, is the 
only Finnish NPHS1 patient (at the age of six years) who has not needed kidney transplantation 
(Patrakka et al., 2000).  
 
Thus, the Finnish patients with compound Fin-major and missense mutations show a graded 
severity of disease from NPHS1 to MCNS. Liu et al (Liu et al., 2001) have shown that most 
missense mutations associated with typical NPHS1 lead to a defective folding of the synthesized 
nephrin, so that the molecule never reaches the podocyte surface. A less severe change (as was the 
case with the R743C-substitution)(Patrakka et al., 2000) would lead to a nephrin molecule that is 
expressed at the slit diaphragm but is functionally defective and may cause an “atypical” phenotype.  
 
We analyzed 35 healthy controls and the R800C-substitution was found in a heterozygous form in 
only one of them. Three patients carried R800C change and two of them had also another defect in 
their nephrin gene. Therefore, R800C is most likely a pathogenic alteration and affects the 
phenotype of the patient no 3, who had Fin-major mutation in the other allele (III, IV).  
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Five additional MCNS patients had heterozygous, non-conservative amino acid substitutions in 
nephrin (G879R; R800C; T294I; A916S; S1058L). Four of these were at conserved sites ( three in 
the Ig-domains and one in the transmembrane domain) based on the comparison of human, rat and 
mouse sequences. Two of the patients also had additional conservative amino acid substitutions 
(S786N; A342G). The variants were not found in public databases dBSNP or SNPper suggesting 
that they are not common polymorphic alterations.  
 
3. Podocin, Neph1 and CD2AP genes in MCNS (IV) 
  
During the recent years our knowledge on the molecular components of the slit diaphragm has 
grown continuously. It is now clear that nephrin is not the only slit diaphragm component and 
genetic variation in other podocyte proteins, such as podocin, NEPH1, CD2AP, α-actinin-4 may 
equally affect the filter function. Moreover, nephrin interacts with other SD components, such as 
Neph1, podocin and CD2AP, and also takes part in cell signaling (Sellin et al., 2003; Shih et al., 
2001; Huber et al., 2001; Schwarz et al., 2001; Roselli et al., 2002). Thus, amino acid changes in 
these proteins would interfere with these functions. 
 
 
In steroid resistant forms of NS, podocin gene mutations play a major role as shown in recent large 
surveys (Caridi et al., 2003; Ruf et al., 2004; Weber et al., 2004). Mutations in the podocin gene 
(NPHS2) cause the autosomal recessive form of FSGS as well as some of the “sporadic” FSGS 
cases (Boute et al., 2000; Karle et al., 2002; Frishberg et al., 2002). However, the situation seems to 
be different in MCNS, in which we found one heterozygous amino acid change (E87 K) in a single 
patient. Some adult patients with FSGS have been found to bear a heterozygous mutation (R229Q), 
which enhances susceptibility to FSGS in association with a second mutant NPHS2 allele 
(Tsukaguchi et al., 2002). Interestingly, podocin with the R229Q amino acid change bound poorly 
to nephrin underscoring the importance of the interplay with these two proteins (Tsukaguchi et al., 
2002).  
 
 
Allelic variants of podocin and CD2AP have been found in patients with NS (Caridi et al., 2004; 
Kim et al., 2003). Recently Pereira et al. (2004) found that the carrier status of a podocin variant 
R229Q showed a strong correlation with albuminuria in individuals from the general population 
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(Pereira et al., 2004). In the present study, four of the 38 MCNS patients had the polymorphic 
R229Q substitution (IV). Since R229Q was similarly detected in 10 % of the controls, the 
significance of this variant in MCNS remains to be solved.  
 
Kim et al. (Kim et al., 2003) found recently that mice who had CD2AP haploinsufficiency, showed 
increased susceptibility to glomerular injury by nephrotoxic antibodies and immune complexes. 
They also identified two human patients who were heterozygous for CD2AP mutations and still had 
proteinuria, implicating CD2AP as a determinant of susceptibility to a glomerular disease. It is also 
possible that mutations in two or more genes are needed to make the glomerular filter susceptible to 
a pathogenic process. In 38 patients with MCNS, however, neither polymorphic variants nor 
nucleotide changes leading to amino acid substitutions could be detected in CD2AP. The results 
indicated that CD2AP gene is highly conserved. Evaluation of the NEPH1 gave similar results; only 
three nucleotide variants having no effect on the amino acid sequence could be observed in 14 of 
the 38 subjects.  
 
 
The pathogenetic role of the heterozygous amino acid substitutions in NPHS1 and NPHS2 genes 
remains to be verified, but it seems possible that they have a dominant-negative effect on the SD 
architecture. The situation would be analogous to that of the Alport syndrome, where heterozygous 
mutations in type IV collagen alpha 3 and 4- genes (COL4A3, COL4A4) can have a dominant-
negative effect on the collagen network and the GBM structure, resulting in a continuous spectrum 
of phenotypes from classical Alport syndrome to benign familial hematuria (Longo et al., 2002; 
Buzza et al., 2003). Respectively, allelic variants of podocin and CD2AP have been associated with 
both nephrosis and slight proteinuria (Caridi et al., 2004; Kim et al., 2003; Pereira et al., 2004). 
Also, minor variants of nephrin seem to be able to modify the phenotype. NPHS1 polymorphism 
(G349A) was found to associate with heavy proteinuria in patients with Ig A nephropathy (Narita et 
al., 2003). Interestingly, the number of NPHS1 sequence variants was significantly higher in MCNS 
patients with a complicated disease. However, the significance of the diverse polymorphic NPHS1 
variants within MCNS patients remained obscure. Besides abundant sequence variants, nine of the 
38 patients had seven different heterozygous amino acid changes most probably affecting the 
nephrin structure. Collectively, it seems that alterations in the nephrin gene may have a 
pathogenetic role in some patients with MCNS, but the role of the alterations in the other SD genes 
studied (podocin, NEPH1, CD2AP) remains minor.  
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 4. Outcome and prognostic factors of MCNS (IV) 
  
The main result of the study on the long term outcome was that the 104 subjects who suffered from 
MCNS in childhood were quite healthy at the mean age of 35 years. Fourteen percent experienced 
proteinuric episodes still as an adult, but repeated steroid treatment was required in only three cases. 
Except for those 14 individuals with continuing proteinuric episodes, nobody had been diagnosed 
for a renal disease as an adult. The prevalence of non-renal health problems was similar to that in 
general population and no long-term side effects of the childhood medications were evident.  
 
The first reports on the long-term outcome of childhood nephrotic syndrome came out already in 
1960´s (Schwartz et al., 1974; Siegel et al., 1972; Wynn et al., 1988) In those studies biopsy 
findings were mostly lacking, therapies were not standardized, and the follow-up times were short. 
In 1980´s, three series of patients usually coming from tertiary hospitals with a biopsy-proven 
MCNS were published (Trompeter et al., 1985; Lewis et al., 1989; Koskimies et al., 1982). The 
follow-up time ranged from five to 21 years so that the oldest patients were young adults at the time 
of the analysis. From 5% to 19% of the patients were reported to have nephrotic episodes in 
adulthood. The studies, however, contained relatively few adult patients. More recently Fakhouri 
and co-workers (Fakhouri et al., 2003) reported the outcome of 102 MCNS patients who were on 
average 27 years old at the time of the evaluation. Up to 42% of their patients experienced at least 
one relapse in adulthood. The high percentage was most probably due to the patient selection, since 
they studied mainly steroid dependent patients.  
 
Our patients (IV) represented an unselected cohort of MCNS children, including cases with no 
relapses. In addition, all patients were treated in the same hospital throughout their childhood Based 
on this and the long follow-up time (average 30 years), quite reliable estimates of the long-term 
evolution of MCNS can be made. Thus, a child in his/her first MCNS episode has roughly a 20% 
chance of no relapses, a 65% chance of childhood relapses only, and a 15% chance of proteinuric 
episodes as an adult. The average number of relapses in this study was three (IV). However, if the 
disease gets more complicated the probability for adulthood proteinuria increases. Thus, if the child 
becomes steroid dependent or the number of episodes exceeds ten, the chance for adulthood 
proteinuric episodes increases to over 40%.  
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The patients of this study were managed by treatment strategies adopted in late 1960´s, in which no 
cyclosporin A (CsA) or other new immunosuppressive drugs were used. Whether the use of CsA 
affects the long term course of MCNS, remains to be seen. Based on the fact that CsA treatment is 
often followed by relapses, it seems that no dramatic change in the long term prognosis of MCNS is 
to be waited in the near future. On the other hand, studies on cultured podocytes have shown that 
CsA may induce apoptosis in podocytes (Fornoni et al., 2001). In theory, this could mean an 
increased risk for developing FSGS, e.g. a more frequent conversion of a benign MCNS to a FSGS 
with a poorer prognosis.  
 
Do some patient characteristics predict a complicated disease? Most of the previous studies report a 
relationship between young age at onset and a more severe clinical course including frequent 
relapses and a longer duration of the disease.(Fakhouri et al., 2003; Trompeter et al., 1985; Lewis et 
al., 1989; Kabuki et al., 1998) In our study, the nine patients with relapses as an adult presented 
with their nephrotic syndrome at a young age (mean 4.0 years). However, also 70% of those who 
had no relapses became proteinuric before the age of six years. Overall, the age at onset was not a 
prognostic factor. Mesangial hypercellularity in the kidney biopsy has also been associated with a 
more severe clinical course. (ISKD, 1981 b) Seventeen patients in our series had mesangial 
changes, but their disease did not differ from that of the children with a “nil” histology. A more 
severe disease has also been reported in children born small for gestational age (Sheu and Chen, 
2001; Zidar et al., 1998). In our series there was no such correlation although the quite small 
number of cases with adequate birth data (52 subjects) limits the reliability of the analysis (precise 
gestational age at birth often missing in 1960´s). However, none of those who experienced 
proteinuria in adulthood weighed less than 3.1 kg at birth. Finally, there was no significant 
difference in the clinical course between boys and girls. 
 
Since MCNS has been associated with disturbances in the immune system, such as allergy and T-
lymphocyte dysfunction, (Van Den Berg and Weening, 2004) it was interesting to evaluate whether 
MCNS children were prone to develop “other” immunological diseases later in the life. Seventeen 
percent of the subjects reported allergic problems (mainly hay fever), which does not more than the 
prevalence in the Finnish population (26%, Finnish adults at 32 years of age)(Huurre et al., 2004). 
On the other hand, the prevalence of diabetes (4.2%), asthma (6.7%) and ulcerative colitis (2.9%) in 
our cohort was slightly higher than in the Finns of similar age (the respective figures: 2.5%, 4.1%, 
0.4%)(Statistics of the National Public Health Institute, Helsinki, Finland) indicating that the 
patients have some – but not strong - tendency for immunological problems.  
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 Another interesting question is whether enrichment of MCNS into families could be detected (IV). 
None of the first degree-relatives had MCNS and only five had had proteinuric episodes arguing 
against a major effect of a susceptibility gene in the pathogenesis of MCNS. This does not, 
however, exclude the possibility that “weakness” in some glomerular proteins could be a co-factor, 
which was supported by the fact that MCNS relapses occurred in some adults after 6-17 years of 
remission.  
 
Despite the fact that our knowledge has greatly increased during the past few years, the molecular 
events leading to proteinuria are still unclarified. It is probable that the pathogenesis of MCNS is of 
a multifactorial origin. Our results, however, suggested for the first time that genetic variants of a 
glomerular filter protein may participate in this pathogenetic process. In conclusion, the results in 
this work favor the idea that proteinuria in MCNS is caused by molecular changes in the slit 
diaphragm structure and the loss of the complex interdigitation of podocyte foot processes is a 
secondary lesion not critical for the development of protein leakage. How SD becomes disrupted in 
MCNS and what is the primary event behind this process remains to be solved. 
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